DMAC vs AAPL: Which Stock is Better?
Side-by-side comparison of DiaMedica Therapeutics Inc and Apple Inc in 2026
DMAC
DiaMedica Therapeutics Inc
$6.45
AAPL
Apple Inc
$326.67
Key Metrics Comparison
| Metric | DMAC | AAPL | Winner |
|---|---|---|---|
| Market Cap | $157.38M | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | DMAC |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | 0.0% | 7.9% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze DMAC
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is DMAC or AAPL a better investment?
Comparing DMAC and AAPL: DiaMedica Therapeutics Inc has a market cap of $157.38M while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between DMAC and AAPL?
DMAC (DiaMedica Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: DMAC or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: DMAC or AAPL?
AAPL has higher revenue growth at 7.9% vs 0.0% for DMAC.
Which company is more profitable: DMAC or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for DMAC.
Which is the larger company: DMAC or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $157.38M for DMAC.
Should I buy DMAC or AAPL in 2026?
Both DMAC and AAPL have investment merit. DMAC trades at $6.45 while AAPL trades at $326.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between DMAC and AAPL stock?
Key differences: Market Cap ($157.38M vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (0.0% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy DMAC or AAPL in 2026?
The choice between DMAC and AAPL depends on your investment goals. AAPL shows higher revenue growth (7.9%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between DMAC and AAPL?
DMAC (DiaMedica Therapeutics Inc) has a market cap of $157.38M, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.